TAMARA MCADAMS: Open Payments
NPI 1548870439 · FARMERVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 27 payments from 8 companies in 2025. Trend: 2023 $379 · 2024 $685 · 2025 $432
Food & beverage: $432
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $152 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| Astellas Pharma US Inc | 2 | $33 |
| Lilly USA, LLC | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, FARXIGA, Kerendia, Veozah, JARDIANCE, Auvelity, Cologuard Collection Kit.
Industry payments across LA — which companies pay providers there.
